Roman G. Rubio, M.D.

Dr. Rubio has served as Adverum’s senior vice president and head of translational medicine since 2014. Previously, Dr. Rubio spent more than 11 years at Genentech, Inc., a member of the Roche Group, where he most recently served as global head of Ophthalmology, leading clinical development and overseeing medical affairs for the Lucentis® and lampalizumab programs. Prior to that, Dr. Rubio served in numerous leadership positions with increasing responsibility in Genentech’s Immunology, Infectious Diseases & Ophthalmology business unit. Dr. Rubio received his MD from the University of California, San Francisco, an MBA from The Wharton School of the University of Pennsylvania, an MS from the University of California, Berkeley, and a BS in Biological Sciences from the University of Notre Dame.